4.5 Article

Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease

Journal

JOURNAL OF NEUROCHEMISTRY
Volume 112, Issue 6, Pages 1539-1551

Publisher

WILEY
DOI: 10.1111/j.1471-4159.2009.06566.x

Keywords

active glycogen synthase kinase-3; Alzheimer's disease; Dickkopf-1; frontotemporal dementia; transgenic mice; beta-catenin

Funding

  1. European Community [LSHB-CT-2005-511977]
  2. UK Alzheimer's Research Trust

Ask authors/readers for more resources

P>To investigate the role of the Wnt inhibitor Dickkopf-1 (DKK-1) in the pathophysiology of neurodegenerative diseases, we analysed DKK-1 expression and localization in transgenic mouse models expressing familial Alzheimer's disease mutations and a frontotemporal dementia mutation. A significant increase of DKK-1 expression was found in the diseased brain areas of all transgenic lines, where it co-localized with hyperphosphorylated tau-bearing neurons. In TgCRND8 mice, DKK-1 immunoreactivity was detected in neurons surrounding amyloid deposits and within the choline acetyltransferase-positive neurons of the basal forebrain. Active glycogen synthase kinase-3 (GSK-3) was found to co-localize with DKK-1 and phospho-tau staining. Downstream to GSK-3, a significant reduction in beta-catenin translocation to the nucleus, indicative of impaired Wnt signaling functions, was found as well. Cumulatively, our findings indicate that DKK-1 expression is associated with events that lead to neuronal death in neurodegenerative diseases and support a role for DKK-1 as a key mediator of neurodegeneration with therapeutic potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available